Principal Investigator Agreement:Principal Investigator Agreement • May 20th, 2019
I, the undersigned, have reviewed this protocol and agree to conduct this protocol in accordance with International Council on Harmonisation Good Clinical Practice (ICH GCP), the ethical principles set forth in the Declaration of Helsinki, and with local regulatory requirements.
Principal Investigator Agreement for Investigational Device StudyPrincipal Investigator Agreement • August 18th, 2020
In accordance with Good Clinical Practice (GCP) and Food and Drug Administration (FDA) regulations, 21 CFR Part 812, Investigational Device Exemptions (IDE), and 21 CFR Part 50, Protection of Human Subjects, this document serves as an Investigator Agreement for:
Principal Investigator AgreementPrincipal Investigator Agreement • January 10th, 2018
WHEREAS Dalhousie has entered into a Research Agreement attached as Appendix A (the “Research Agreement”) with for the project titled “” (the “Project”);
